Kymera Therapeutics (KYMR) Insider Trading & Ownership $29.11 +0.54 (+1.89%) Closing price 05/7/2025 04:00 PM EasternExtended Trading$29.11 0.00 (0.00%) As of 08:40 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Kymera Therapeutics (NASDAQ:KYMR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage15.82%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$20.63 M Get KYMR Insider Trade Alerts Want to know when executives and insiders are buying or selling Kymera Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address KYMR Insider Buying and Selling by Quarter Kymera Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/3/2025Bruce N JacobsCFOSell7,035$30.45$214,215.75 3/3/2025Ellen ChiniaraInsiderSell2,241$30.45$68,238.45 3/3/2025Jeremy G ChadwickCOOSell1,383$30.45$42,112.35 1/6/2025Ellen ChiniaraInsiderSell3,129$41.75$130,635.75 9/17/2024Pamela EspositoDirectorSell13,500$48.28$651,780.00 8/26/2024Jeffrey W. AlbersDirectorSell5,000$49.10$245,500.00 7/16/2024Jared GollobInsiderSell23,145$45.81$1,060,272.45 7/9/2024Bruce BoothDirectorSell453,960$38.21$17,345,811.60 6/12/2024Bruce BoothDirectorSell16,740$35.45$593,433.00 6/7/2024Joanna HorobinDirectorSell8,500$32.99$280,415.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. (Data available from 1/1/2013 forward) KYMR Insider Trading Activity - Frequently Asked Questions Who is on Kymera Therapeutics's Insider Roster? The list of insiders at Kymera Therapeutics includes Bruce Booth, Bruce N Jacobs, Bvf Partners L P/Il, Ellen Chiniara, Jared Gollob, Jeffrey W. Albers, Jeremy G Chadwick, Joanna Horobin, Pamela Esposito, and Venture Fund X L.P. Atlas. Learn more on insiders at KYMR. What percentage of Kymera Therapeutics stock is owned by insiders? 15.82% of Kymera Therapeutics stock is owned by insiders. Learn more on KYMR's insider holdings. Which Kymera Therapeutics insiders have been buying company stock? The following insider purchased KYMR shares in the last 24 months: Bvf Partners L P/Il ($2,518,965.84). How much insider buying is happening at Kymera Therapeutics? Insiders have purchased a total of 216,406 KYMR shares in the last 24 months for a total of $2,518,965.84 bought. Which Kymera Therapeutics insiders have been selling company stock? The following insiders have sold KYMR shares in the last 24 months: Bruce Booth ($28,916,789.09), Bruce N Jacobs ($378,892.99), Ellen Chiniara ($273,275.30), Jared Gollob ($2,698,135.95), Jeffrey W. Albers ($717,234.25), Jeremy G Chadwick ($42,112.35), Joanna Horobin ($280,415.00), Pamela Esposito ($651,780.00), and Venture Fund X L.P. Atlas ($6,672,891.40). How much insider selling is happening at Kymera Therapeutics? Insiders have sold a total of 1,021,979 Kymera Therapeutics shares in the last 24 months for a total of $40,631,526.33 sold. Kymera Therapeutics Key ExecutivesDr. Bruce L. Booth DPHIL (Age 50)Ph.D., Co-Founder & Independent Chairman Compensation: $75kDr. Nello Mainolfi M.D. (Age 45)Ph.D., Co-Founder, President, CEO & Director Compensation: $1.08MMr. Bruce N. Jacobs CFAChief Financial Officer1 recent tradesDr. Jeremy G. Chadwick Ph.D. (Age 61)Chief Operating Officer Compensation: $883kMs. Ellen V. Chiniara Esq. (Age 65)J.D., Chief Legal Officer & Corporate Secretary Compensation: $640.35kDr. Jared A. Gollob M.D. (Age 59)Chief Medical Officer Compensation: $723.6kMs. Karen WeisbachHead of People & CultureDr. Juliet Williams B.A Ph.D.Head of Research More Insider Trading Tools from MarketBeat Related Companies ROIV Insider Trading RVMD Insider Trading LNTH Insider Trading BBIO Insider Trading TGTX Insider Trading SRPT Insider Trading ADMA Insider Trading BPMC Insider Trading VRNA Insider Trading NUVL Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Top-Ranked Insider Buys From April by Market CapMcDonald’s Insiders Sell Shares! Investors Should Do the Opposite5 Mid-Cap Stocks Insiders Are Buying This YearInsider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You? This page (NASDAQ:KYMR) was last updated on 5/8/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredTrump to redistribute trillions of dollars Seeing how the media and other analysts are covering Trump’s actions – it’s laughable. At least it would be la...Porter & Company | Sponsored270x more lucrative than NVIDIA???270x more lucrative than NVIDIA??? If you've missed out on NVIDIA's recent 1,600% run... Don't worry. ...Behind the Markets | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredVanishing BenefitsWhat would you do if your next Social Security check simply never arrived? If you called and the line was d...Investors Alley | SponsoredSilver’s 332% Surge?Silver has quietly become one of the most promising investments of this cycle. Russia is now stockpiling silve...Lear Capital | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kymera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kymera Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KYMR Stock Free KYMR Stock Alerts